author_facet Huang, James J.
Newton, Robert C.
Horuk, Richard
Matthew, James B.
Covington, Maryanne
Pezzella, Kathleen
Lin, Yuan
Huang, James J.
Newton, Robert C.
Horuk, Richard
Matthew, James B.
Covington, Maryanne
Pezzella, Kathleen
Lin, Yuan
author Huang, James J.
Newton, Robert C.
Horuk, Richard
Matthew, James B.
Covington, Maryanne
Pezzella, Kathleen
Lin, Yuan
spellingShingle Huang, James J.
Newton, Robert C.
Horuk, Richard
Matthew, James B.
Covington, Maryanne
Pezzella, Kathleen
Lin, Yuan
FEBS Letters
Muteins of human interleukin‐1 that show enhanced bioactivities
Cell Biology
Genetics
Molecular Biology
Biochemistry
Structural Biology
Biophysics
author_sort huang, james j.
spelling Huang, James J. Newton, Robert C. Horuk, Richard Matthew, James B. Covington, Maryanne Pezzella, Kathleen Lin, Yuan 0014-5793 1873-3468 Wiley Cell Biology Genetics Molecular Biology Biochemistry Structural Biology Biophysics http://dx.doi.org/10.1016/0014-5793(87)80307-1 <jats:p>Using recombinant DNA techniques, we have made a series of amino‐terminal muteins of human interleukin‐1 (IL‐1). Two of the muteins demonstrated 4–7‐fold increase in bioactivity as compared to that of the native IL‐1. The enhanced biological potency coincides with an increase in both receptor binding affinity and in vivo tumor inhibitory activity. By site specific mutagenesis, we have shown that the arginine at the fourth position of IL‐1 is one of the key residues in the function of IL‐1. Circular dichroism studies of the amino‐terminus analogs showed little structural rearrangement. The change in bioactivity might be due to a change in the stability of the muteins, in the side chain interactions with receptors or in the minor change in folding near the receptor binding site.</jats:p> Muteins of human interleukin‐1 that show enhanced bioactivities FEBS Letters
doi_str_mv 10.1016/0014-5793(87)80307-1
facet_avail Online
Free
finc_class_facet Biologie
Chemie und Pharmazie
Physik
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi8wMDE0LTU3OTMoODcpODAzMDctMQ
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi8wMDE0LTU3OTMoODcpODAzMDctMQ
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint Wiley, 1987
imprint_str_mv Wiley, 1987
issn 1873-3468
0014-5793
issn_str_mv 1873-3468
0014-5793
language English
mega_collection Wiley (CrossRef)
match_str huang1987muteinsofhumaninterleukin1thatshowenhancedbioactivities
publishDateSort 1987
publisher Wiley
recordtype ai
record_format ai
series FEBS Letters
source_id 49
title Muteins of human interleukin‐1 that show enhanced bioactivities
title_unstemmed Muteins of human interleukin‐1 that show enhanced bioactivities
title_full Muteins of human interleukin‐1 that show enhanced bioactivities
title_fullStr Muteins of human interleukin‐1 that show enhanced bioactivities
title_full_unstemmed Muteins of human interleukin‐1 that show enhanced bioactivities
title_short Muteins of human interleukin‐1 that show enhanced bioactivities
title_sort muteins of human interleukin‐1 that show enhanced bioactivities
topic Cell Biology
Genetics
Molecular Biology
Biochemistry
Structural Biology
Biophysics
url http://dx.doi.org/10.1016/0014-5793(87)80307-1
publishDate 1987
physical 294-298
description <jats:p>Using recombinant DNA techniques, we have made a series of amino‐terminal muteins of human interleukin‐1 (IL‐1). Two of the muteins demonstrated 4–7‐fold increase in bioactivity as compared to that of the native IL‐1. The enhanced biological potency coincides with an increase in both receptor binding affinity and in vivo tumor inhibitory activity. By site specific mutagenesis, we have shown that the arginine at the fourth position of IL‐1 is one of the key residues in the function of IL‐1. Circular dichroism studies of the amino‐terminus analogs showed little structural rearrangement. The change in bioactivity might be due to a change in the stability of the muteins, in the side chain interactions with receptors or in the minor change in folding near the receptor binding site.</jats:p>
container_issue 2
container_start_page 294
container_title FEBS Letters
container_volume 223
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792337244115173385
geogr_code not assigned
last_indexed 2024-03-01T15:12:47.907Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Muteins+of+human+interleukin%E2%80%901+that+show+enhanced+bioactivities&rft.date=1987-11-02&genre=article&issn=1873-3468&volume=223&issue=2&spage=294&epage=298&pages=294-298&jtitle=FEBS+Letters&atitle=Muteins+of+human+interleukin%E2%80%901+that+show+enhanced+bioactivities&aulast=Lin&aufirst=Yuan&rft_id=info%3Adoi%2F10.1016%2F0014-5793%2887%2980307-1&rft.language%5B0%5D=eng
SOLR
_version_ 1792337244115173385
author Huang, James J., Newton, Robert C., Horuk, Richard, Matthew, James B., Covington, Maryanne, Pezzella, Kathleen, Lin, Yuan
author_facet Huang, James J., Newton, Robert C., Horuk, Richard, Matthew, James B., Covington, Maryanne, Pezzella, Kathleen, Lin, Yuan, Huang, James J., Newton, Robert C., Horuk, Richard, Matthew, James B., Covington, Maryanne, Pezzella, Kathleen, Lin, Yuan
author_sort huang, james j.
container_issue 2
container_start_page 294
container_title FEBS Letters
container_volume 223
description <jats:p>Using recombinant DNA techniques, we have made a series of amino‐terminal muteins of human interleukin‐1 (IL‐1). Two of the muteins demonstrated 4–7‐fold increase in bioactivity as compared to that of the native IL‐1. The enhanced biological potency coincides with an increase in both receptor binding affinity and in vivo tumor inhibitory activity. By site specific mutagenesis, we have shown that the arginine at the fourth position of IL‐1 is one of the key residues in the function of IL‐1. Circular dichroism studies of the amino‐terminus analogs showed little structural rearrangement. The change in bioactivity might be due to a change in the stability of the muteins, in the side chain interactions with receptors or in the minor change in folding near the receptor binding site.</jats:p>
doi_str_mv 10.1016/0014-5793(87)80307-1
facet_avail Online, Free
finc_class_facet Biologie, Chemie und Pharmazie, Physik
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi8wMDE0LTU3OTMoODcpODAzMDctMQ
imprint Wiley, 1987
imprint_str_mv Wiley, 1987
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 1873-3468, 0014-5793
issn_str_mv 1873-3468, 0014-5793
language English
last_indexed 2024-03-01T15:12:47.907Z
match_str huang1987muteinsofhumaninterleukin1thatshowenhancedbioactivities
mega_collection Wiley (CrossRef)
physical 294-298
publishDate 1987
publishDateSort 1987
publisher Wiley
record_format ai
recordtype ai
series FEBS Letters
source_id 49
spelling Huang, James J. Newton, Robert C. Horuk, Richard Matthew, James B. Covington, Maryanne Pezzella, Kathleen Lin, Yuan 0014-5793 1873-3468 Wiley Cell Biology Genetics Molecular Biology Biochemistry Structural Biology Biophysics http://dx.doi.org/10.1016/0014-5793(87)80307-1 <jats:p>Using recombinant DNA techniques, we have made a series of amino‐terminal muteins of human interleukin‐1 (IL‐1). Two of the muteins demonstrated 4–7‐fold increase in bioactivity as compared to that of the native IL‐1. The enhanced biological potency coincides with an increase in both receptor binding affinity and in vivo tumor inhibitory activity. By site specific mutagenesis, we have shown that the arginine at the fourth position of IL‐1 is one of the key residues in the function of IL‐1. Circular dichroism studies of the amino‐terminus analogs showed little structural rearrangement. The change in bioactivity might be due to a change in the stability of the muteins, in the side chain interactions with receptors or in the minor change in folding near the receptor binding site.</jats:p> Muteins of human interleukin‐1 that show enhanced bioactivities FEBS Letters
spellingShingle Huang, James J., Newton, Robert C., Horuk, Richard, Matthew, James B., Covington, Maryanne, Pezzella, Kathleen, Lin, Yuan, FEBS Letters, Muteins of human interleukin‐1 that show enhanced bioactivities, Cell Biology, Genetics, Molecular Biology, Biochemistry, Structural Biology, Biophysics
title Muteins of human interleukin‐1 that show enhanced bioactivities
title_full Muteins of human interleukin‐1 that show enhanced bioactivities
title_fullStr Muteins of human interleukin‐1 that show enhanced bioactivities
title_full_unstemmed Muteins of human interleukin‐1 that show enhanced bioactivities
title_short Muteins of human interleukin‐1 that show enhanced bioactivities
title_sort muteins of human interleukin‐1 that show enhanced bioactivities
title_unstemmed Muteins of human interleukin‐1 that show enhanced bioactivities
topic Cell Biology, Genetics, Molecular Biology, Biochemistry, Structural Biology, Biophysics
url http://dx.doi.org/10.1016/0014-5793(87)80307-1